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Traditionally, hip dysplasia is considered a joint disease with 
insufficient coverage of the femoral head, which is related to 
early painful degenerative changes (Mechlenburg 2008, Ross 
et al. 2011). Pain and physical function can be improved by 
periacetabular osteotomy (PAO) (Hartig-Andreasen et al. 
2012, Lerch et al. 2017), a well-established surgical treatment 
of symptomatic hip dysplasia in young patients. We have 
previously challenged this traditional understanding as we 
reported a high prevalence of muscle–tendon pain in young 
patients with hip dysplasia, which negatively affected patient-
reported outcome (PRO) (Jacobsen et al. 2018b). 
PAO is commonly investigated with patient-reported out-
come measures (PROMs) developed for older patients with 
osteoarthritis (Hartig-Andreasen et al. 2012, Clohisy et al. 
2017). In young patients, however, a high score on a PROM 
designed for older patients does not necessarily indicate an 
acceptable health status, as more strenuous activities such as 
sports and recreational activities are not evaluated. 
Only a few previous studies have investigated PRO after 
PAO with PROMs developed for young and physically active 
patients (Jacobsen et al. 2014, Khan et al. 2017). In these stud-
ies, outcomes were investigated with the Non Arthritic Hip 
Score (NAHS) and the Copenhagen Hip and Groin Outcome 
Score (HAGOS). The results of the studies showed medium to 
very large effect sizes. The NAHS, however, was developed 
for and validated in patients with hip osteoarthritis (Khan 
et al. 2017), while the study using HAGOS was fairly small 
and focused on objective gait characteristics rather than PRO 
(Jacobsen et al. 2014). Therefore, it is warranted to investi-
gate the outcome of the PAO with PROMs designed for young 
and active patients, including the possible negative effect of 
muscle–tendon pain.
We investigated changes in PRO, changes in muscle–tendon 
pain, and any associations between them from before to 1 year 
after PAO.
Background and purpose — Larger prospective studies 
investigating periacetabular osteotomy (PAO) with patient-
reported outcome measures developed for young patients 
are lacking. We investigated changes in patient-reported out-
come (PRO), changes in muscle–tendon pain, and any asso-
ciations between them from before to 1 year after PAO.
Patients and methods — Outcome after PAO was inves-
tigated in 82 patients. PRO was investigated with the Copen-
hagen Hip and Groin Outcome Score (HAGOS). Muscle–
tendon pain in the hip and groin region was identified with 
standardized clinical tests, and any associations between 
them were analyzed with multivariable linear regressions.
Results — HAGOS subscales improved statistically sig-
nificantly from before to 1 year after PAO with effect sizes 
ranging from medium to very large (0.66–1.37). Muscle–
tendon pain in the hip and groin region showed a large 
decrease in prevalence from 74% (95% CI 64–83) before 
PAO to 35% (95% CI 25–47) 1 year after PAO. Statistically 
significant associations were observed between changes 
in HAGOS and change in the sum of muscle–tendon pain, 
ranging from –4.7 (95% CI –8.4 to –1.0) to –8.2 (95% CI 
–13 to –3.3) HAGOS points per extra painful entity across 
all subscales from before to 1 year after PAO.
Interpretation — Patients with hip dysplasia experi-
ence medium to very large improvements in PRO 1 year 
after PAO, associated with decreased muscle–tendon pain. 
The understanding of hip dysplasia as solely a joint disease 
should be reconsidered since muscle–tendon pain seems to 
play an important role in relation to the outcome after PAO.
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Patients and methods
Patients from the Department of Orthopaedics at Aarhus Uni-
versity Hospital in Denmark were prospectively included from 
May 2014 to August 2015. They were part of a study popula-
tion from a previous study (Jacobsen et al. 2018b) and were 
included if Wiberg’s centre-edge (CE) angle was < 25° (Wiberg 
1939), if they had had groin pain for at least 3 months, and if 
they were scheduled for PAO. Furthermore, only patients < 
45 years, with BMI < 30, normal range of motion (minimum 
110° of hip flexion), and with Tönnis’s osteoarthritis grade < 2 
(Tönnis 1987) were operated on. Patients with comorbidities 
and previous surgical interventions affecting their hip function 
were excluded. Further details on study design are reported in 
our previous studies on the same study population, reporting 
prevalence of muscle–tendon pain and structural abnormali-
ties before PAO (Jacobsen et al. 2018a, 2018b).
Before PAO, patient characteristics including age, sex, 
and duration of pain were recorded based on standardized 
questions. A single rater measured the CE angle, the Tönnis 
acetabular index (AI) angle (Tönnis 1987), and the Tönnis 
osteoarthritis grade on standing anteroposterior radiographs. 
Information on comorbidities and previous treatments was 
extracted from hospitals charts. Pain was recorded using the 
FABER (Flexion/Abduction/External Rotation) test and the 
FADDIR (Flexion/Adduction/Internal Rotation) test (Tro-
elsen et al. 2009, Martin et al. 2010). Additionally, a standard-
ized test was used to record occurrence of internal snapping 
hip (Tibor and Sekiya 2008). 
Periacetabular osteotomy
The minimally invasive transsartorial approach for PAO was 
performed by 2 experienced orthopedic surgeons via 3 sepa-
rate osteotomies (Troelsen et al. 2008). In short, an approxi-
mately 7 cm incision was made alongside the sartorius muscle 
beginning at the anterior superior iliac spine. The sartorius 
muscle was divided parallel with the direction of its fibers. 
The medial part of the split muscle was retracted medially 
together with the iliopsoas muscle, and this was followed by 
osteotomies. The patients were presented with a standardized 
post-surgery rehabilitation program on the ward, and dis-
charged after approximately 2 days of hospitalization. Partial 
weight-bearing was allowed in the first 6–8 weeks. Moreover, 
all patients were offered an individual-based rehabilitation 
program of 2 weekly training sessions starting 6 weeks after 
PAO and lasting generally for 2–4 months. 
Patient-reported outcome measure
The HAGOS was completed before and 1 year after PAO 
by all patients prior to assessment of muscle–tendon pain. 
HAGOS consists of 6 separate subscales covering pain, symp-
toms, physical function in daily living (ADL), physical func-
tion in sports and recreation (sports/recreation), participation 
restriction (PA), and quality of life (QOL) (Thorborg et al. 
2011). HAGOS is tailored to reflect physically active young 
and middle-aged patients with long-standing hip and/or groin 
pain. HAGOS measures the patient’s hip-related disability 
during the past week on a scale from 0 to 100 points, where 
100 points indicates best possible outcome. 
Pain at rest was measured before and 1 year after PAO on 
a numeric rating scale (NRS) from 0 (no pain) to 10 (unbear-
able pain). 
Muscle–tendon pain
We assessed muscle–tendon pain before and 1 year after PAO 
with standardized clinical examinations originally proposed 
by Hölmich et al. (2004) and modified by the Doha consensus 
statement (Weir et al. 2015). The standardized examination 
covers a number of pain-provoking tests including anatomi-
cal palpation, resistance testing, and passive muscle stretch in 
specific anatomical regions, named clinical entities (Weir et 
al. 2015). In our study, we added identification of pain in the 
hamstrings and abductors following the same principle as the 
other clinical entities, since these structures were considered 
important in our study. Moreover, pain related to the rectus 
abdominis (Hölmich et al. 2004) was the focus in this study as 
an alternative to inguinal-related pain defined in the Doha con-
sensus since most patients were women. Muscle–tendon pain 
was assessed in 5 anatomical entities: the iliopsoas, the abduc-
tors, the adductors, the hamstrings, and the rectus abdominis. 
Muscle–tendon pain was investigated within each entity and 
as the sum of positive clinical entities for each patient, ranging 
from 0 to 5. The outcome of each entity test was dichotomous 
(pain yes or no).
Sample size considerations
The aim of this study was to investigate 1-year outcome of the 
PAO using HAGOS. Moderate effect sizes were considered 
relevant, which would require a sample size of 85 patients to 
show an effect size of 0.5 from before to 1 year after PAO. 
This sample size is based on a power of 90% and a signifi-
cance level of 5%.
Statistics
Parametric continuous data were reported as means with 
standard deviations (SD) if normally distributed, otherwise 
reported as medians with interquartile ranges (IQR). Histo-
grams and probability plots were used to test for normal-
ity. Categorical data were reported as numbers of events and 
percentage with a 95% confidence interval (CI). Changes 
in each HAGOS subscale measured before and 1 year after 
PAO were considered important and were tested with paired 
t-tests. Similarly, changes in each muscle–tendon pain entity 
from before to 1 year after PAO were considered equally 
important. These were tested with the McNemar test. Effect 
sizes of HAGOS and muscle–tendon pain were calcu-
lated from the paired t-test as Cohen’s d on the formula: 
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t statistic/√(n), and from McNemar test as Cohen’s w on the 
formula: w statistic/√(n). Finally, crude and adjusted multi-
variable linear regression analyses were performed to assess 
associations between changes in HAGOS (pain, symptoms, 
ADL, sport/recreation, PA, and QOL) and change in the 
sum of muscle–tendon pain entities (i.e., the sum of positive 
clinical entities for each patient) from before to 1 year after 
PAO. Changes in each HAGOS subscale were the dependent 
variables, and the sum of muscle–tendon pain entities for 
each patient was the independent variable. Potential co-vari-
ates were identified using causal diagrams for observational 
research, based on knowledge from previous studies (Green-
land et al. 1999). Co-variates included in the analysis were 
CE angles measured before and 1 year after PAO (continu-
ous), age (continuous), and sex (dichotomous). Crude and 
adjusted β-coefficients were estimated and the assumptions 
(independent observations, linear association, constant vari-
ance of residuals, and normal distribution of residuals) of the 
regression models were met. The β-coefficients refer to the 
slope of the regression line, indicating a decrease in changed 
PRO per unit increase in muscle–tendon pain. The STATA 
14.0 (StataCorp, College Station, TX, USA) software pack-
age was used for data analysis, and results were considered 
statistically significant if p < 0.05. 
Ethics, registration, funding, and potential conflicts of 
interest 
This study was conducted and reported in accordance with the 
WMA declaration of Helsinki and the STROBE statement. 
All patients gave informed consent to participate, and ethi-
cal approval was obtained from the Central Denmark Region 
Committee on Biomedical Research Ethics (5/2014). The 
Danish Data Protection Agency (1-16-02-47-14) authorized 
the handling of personal data, and the protocol was registered 
at ClinicalTrials.gov (20140401PAO). This study was funded 
by the Danish Rheumatism Association, the Aase and Ejnar 
Danielsen Fund, and the Fund of Family Kjaersgaard, Sunds. 
The authors declare that they have no potential conflicts of 
interest.
Results 
Informed consent was obtained from 100 consecutive patients 
before PAO. 18 patients were lost to follow-up (Figure), leav-
ing 82 patients for this study (Table 1). We found no statisti-
cally significant differences in any of the listed patient char-
acteristics between the 18 patients lost to follow-up and the 
analyzed patients (data not shown).
Patient-reported outcome 
We found statistically significant increases in all HAGOS sub-
scales from before to 1 year after PAO (Table 2). The effect 
Flowchart of the study process. 100 consecutive patients 
with symptomatic hip dysplasia scheduled for periacetabu-
lar osteotomy (PAO) were included from Department of 
Orthopedic Surgery, Aarhus University Hospital, Denmark.
Patients scheduled for PAO
with informed consent
n = 100
Lost to 1-year follow-up (n = 18):
– postponed surgery, 7
– time and transportation, 4
– serious disease unrelated to PAO, 3
– injuries unrelated to PAO, 2




Table 1. Characteristics of 82 consecutive patients with hip dys-
plasia
 
Patient characteristics Before PAO 1 year after PAO
Age, years a 30 (9) 31 (9)
BMI a 23 (3) 24 (3)
Men, n 11 –
Duration of pain, years b   3 (1–6) –
Bilateral hip dysplasia, n 74 –
CE angle (°) a 17 (5) 30 (5)
AI angle (°) a 14 (5)   3 (4)
Tönnis’s osteoarthritis grade 1, n   3    5
Positive FADIR test, n 70 55
Positive FABER test, n 62 47
Positive internal snapping hip test, n 25 16
Characteristics are presented as numbers or
a mean values (standard deviation),
b median values (interquartile range)
Abbreviations: CE = centre-edge, AI = Tönnis’s acetabular index, 
FADIR = Flexion/Adduction/Internal Rotation, 
FABER = Flexion/Abduction/External Rotation.
Table 2. Patient-reported outcome of PAO in 82 patients with hip dysplasia 
  1 year
 Before PAO after PAO Difference Effect size 
Outcome score  mean (SD) mean (SD) mean (CI) Cohen’s d p-value
HAGOS
 Pain 50 (17) 76 (17) 26 (22–30) 1.37 < 0.001
 Symptoms 48 (17) 67 (19) 19 (15–23) 0.99 < 0.001
 ADL 55 (22) 81 (18) 27 (22–31) 1.25 < 0.001
 Sport/recreation 39 (21) 64 (23) 25 (20–31) 1.02 < 0.001
 PA 23 (24) 44 (33) 21 (14–28) 0.66 < 0.001 
 Quality of life 29 (14) 57 (25) 28 (22–33) 1.11 < 0.001
NRS Pain (IQR) 3 (2–5) 0 (0–2)  0.74 < 0.001
Abbreviations: HAGOS = Copenhagen Hip and Groin Outcome Score (0–100 points), 
ADL = physical function in daily living, PA = preferred physical activity participa-
tion, NRS = numeric rating scale, IQR = interquartile range. 
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sizes ranged from 0.66 to 1.37, corresponding to medium to 
very large effect sizes. Moreover, 26/82 patients reported a 
sport/recreation score of 0–50 points 1 year after PAO, 14/82 
patients reported a sport/recreation score of >50–70 points, 
while 42/82 patients reported a sport/recreation score >70 
points 1 year after PAO. Similarly, NRS pain decreased sta-
tistically significantly, corresponding to a medium effect size 
of 0.74.
Muscle–tendon pain
The analysis of the individual entities showed a significant 
decrease in iliopsoas-related pain and abductor-related pain 
from before to 1 year after PAO, whereas the decrease in 
the other 3 entities was not statistically significant (Table 3). 
Moreover, the proportion of patients with minimum 1 positive 
muscle–tendon pain entity decreased by 39 percentage points 
(CI 24–54) 1 year after PAO.
Associations between changes in HAGOS and 
change in muscle–tendon pain 
Apart from HAGOS PA, both crude and adjusted analyses 
showed statistically significant negative linear association 
between changes in HAGOS and change in the sum of muscle–
tendon pain entities, ranging from –4.7 to –8.2 HAGOS points 
per extra painful entity across all subscales from before to 1 
year after PAO (Table 4). 
change in the sum of muscle–tendon pain was associated with 
changes in PRO of the PAO. 
Only 2 previous studies have investigated the outcome of 
PAO with PROMs tailored to reflect activity levels of young 
and active patients. Jacobsen et al. (2014) reported PRO after 
PAO, applying HAGOS, and found medium to very large 
improvements corresponding to effect sizes from 0.78 to 
1.75 in a study population of 29 patients with hip dysplasia. 
Similarly, a consecutive study on 168 patients with hip dys-
plasia reported very large patient-reported improvement cor-
responding to an effect size of 1.5 measured with the NAHS 
(Khan et al. 2017). The HAGOS subscale scores, we found, 
ranged from 44 to 81 points, which is in accordance with the 
study by Jacobsen et al. (2014), reporting scores of 50 to 90 
HAGOS points 1 year after PAO in another series of patients. 
The association between change in HAGOS PA and change 
in the sum of muscle–tendon pain entities was not statisti-
cally significant. However, the lack of association between 
change in HAGOS PA and change in muscle–tendon pain 
can be explained since HAGOS PA measures patients’ self-
perceived ability to participate in a preferred physical activ-
ity (Thorborg et al. 2011), which is not related to specific 
functions and activities like the other HAGOS subscales. 
Therefore, it is not surprising that perceived participatory 
capacity is not reflected in change in muscle–tendon pain 
and vice versa. 
Table 3. Muscle–tendon pain in 82 patients with hip dysplasia
 
Clinical entities Before PAO 1 year after PAO Difference Effect size 
  % (CI) % (CI) % points (CI) Cohen’s w p-value
Iliopsoas-related pain 54 (42–65) 22 (14–32) –32 (–46 to –17) –1.96 < 0.001
Abductor-related pain 37 (26–48) 15 (8–24) –22 (–36 to –8) –1.12 0.002
Adductor-related pain 12 (6–21)   7 (3–15)   –5 (–16 to 6) –0.11 0.5
Hamstrings-related pain   6 (2–14)   1 (0–7)   –5 (–12 to 2) –0.29 0.2
Rectus-abdominis-related pain   4 (0–10)   0 (0–0)   –4 (–9 to 2) –0.33 0.3
Patients with minimum 1 
   positive clinical entity 74 (64–83) 35 (25 to 47) –39 (–54 to –24) –2.46 < 0.001
 
Table 4. Associations between change in HAGOS (0–100 points) and change in 
muscle–tendon pain (n = 82)
 Crude Adjusted a
HAGOS β coefficient (CI) p-value β coefficient (CI) p-value
 
Pain –4.7 (–8.5 to –0.9) 0.02 –4.7 (–8.4 to –1.0) 0.01
Symptoms –4.8 (–8.6 to –1.0) 0.02 –4.7 (–8.6 to –0.9) 0.02
ADL –6.1 (–10 to –1.9) 0.005 –6.2 (–10 to –2.1) 0.004
Sport/recreation –5.9 (–11 to –1.0) 0.02 –6.0 (–11 to –0.9) 0.02
PA –1.2 (–7.9 to 5.5) 0.7 –1.2 (–7.9 to 5.6) 0.7
Quality of life –8.2 (–13 to –3.3) 0.001 –8.2 (–13 to –3.3) 0.001
 
a Adjusted for CE angles measured before and 1 year after PAO, age, and sex. 
Abbreviations: See Table 2
Discussion
We investigated changes in PRO, changes in 
muscle–tendon pain, and any associations between 
them from before to 1 year after PAO. Our patients 
reported clinically relevant improvements in all 
HAGOS subscales with effect sizes ranging from 
medium to very large. All improvements were 
higher than the minimally important change (MIC) 
of the HAGOS (Thomeé et al. 2014). Neverthe-
less, 1 year after PAO, one-third of the patients 
still experienced muscle–tendon pain, most com-
monly affecting the iliopsoas and the hip abductors. 
Furthermore, our regression analyses showed that 
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We did not include a healthy control group; however, an 
age- and sex-matched healthy control group was included in 
a previous study, investigating the outcome 1 year after PAO 
using HAGOS (Jacobsen et al. 2014). All healthy subjects 
reported a PRO of 84–100 HAGOS sport/recreation points, 
which was different from the HAGOS sport/recreation score 
measured 1 year after PAO in the patients with hip dyspla-
sia (Jacobsen et al. 2014). In this study, half of the patients 
reported a HAGOS score ≤ 70 sport/recreation points 1 year 
after PAO. This indicates that patients still experience a low 
functional level, associated with muscle–tendon pain.
Our patients showed a clinically relevant reduction in pain 
related to the iliopsoas and the hip abductors. This decrease 
may be a result of both surgical reorientation and the inten-
sive individual-based rehabilitation program. The effect of 
muscle–tendon pain on changes in HAGOS score was 5–8 
HAGOS points for every change in number of painful clini-
cal entities across all HAGOS subscales, which is in line with 
the MIC of HAGOS (Thomeé et al. 2014). This suggests that 
resolving just 1 painful clinical entity after PAO has a clini-
cally relevant impact on the outcome 1 year after PAO. 
Muscle–tendon affection in patients with hip dysplasia 
has only been reported in 1 previous study, which reported 
muscle–tendon affection among one-fifth of the patients iden-
tified by hip arthroscopy (Domb et al. 2014). However, associ-
ations between muscle–tendon affection and patient-reported 
outcomes were not investigated. 
Methodological considerations and limitations
As reported in our previous study on the same study popula-
tion, we found low inter-rater reliability of the muscle–tendon 
pain assessment, indicating a high random variation in our 
estimates (Jacobsen et al. 2018b). The potentially negative 
impact of this is small because we included a large study 
population. The associations between changes in HAGOS 
and change in the sum of muscle–tendon pain were mainly 
driven by patients who either reduced many painful entities 
or increased the number of painful entities 1 year after PAO. 
The same analysis without these patients would have resulted 
in smaller associations or even lack of significant associations 
between HAGOS and muscle–tendon pain. 
Summary
Patients with hip dysplasia experience medium to very large 
improvements in PRO 1 year after PAO, associated with 
decreased muscle–tendon pain. The understanding of hip 
dysplasia as solely a joint disease should be reconsidered as 
muscle–tendon pain seems to play an important role in rela-
tion to the outcome after PAO. Future intervention studies 
ought to investigate the optimal treatment for patients with hip 
dysplasia and coexisting muscle–tendon pain. 
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